CoChat

Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP‐CTFs), associated with tau pathology stages, in Alzheimer's disease

Sergeant, Nicolas, David, Jean‐Philippe, Champain, Danie, Ghestem, Antoine, Wattez, Annick, Delacourte, André · 2002 · Journal of Neurochemistry
Cited by 66

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Amyloid precursor protein (APP) dysfunction is a key aetiologic agent in Alzheimer's disease (AD). The processing of this transmembrane protein generates carboxy terminal fragments (CTFs) upstream of β‐amyloid peptide (Aβ) production. The physiologic significance of APP‐CTFs is still poorly understood, as well as the relationship that could link APP dysfunction and tau pathology in familial and non‐familial AD (non‐FAD). In the present study, we have investigated the quantitative and qualitative changes of APP‐CTFs in different brain areas of non‐demented and demented patients from a prospective and multidisciplinary study. A significant decrease of the five APP‐CTFs was observed, which correlated well with the progression of tau pathology, in most cases with infraclinical AD and AD, either familial or non‐FAD. Furthermore, solubility properties and the ratio between the five bands were also modified, both in the Triton‐soluble and/or ‐insoluble fractions. Together, we show here for the first time a modification directly observed on APP‐CTFs upstream of Aβ products and its relationship with tau pathology, which could reflect the basic aetiological mechanisms of AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1471-4159.2002.00901.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 66

Metadata

Authors
Sergeant, N., David, J., Champain, D., Ghestem, A., Wattez, A., & Delacourte, A.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2002-05-07
Volume
81
Issue
4
Pages
663-672
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2128034850
Cited by
66
References
2
FWCI
4.04
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP‐CTFs), associated with tau pathology stages, in Alzheimer's disease. https://app.cochat.ai/papers/10.1046/j.1471-4159.2002.00901.x
The paper
Sergeant, N., David, J., Champain, D., Ghestem, A., Wattez, A., & Delacourte, A. (2002). Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP‐CTFs), associated with tau pathology stages, in Alzheimer's disease. Journal of Neurochemistry. https://doi.org/10.1046/j.1471-4159.2002.00901.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.